Opendata, web and dolomites

CoaguPOC

SMART POINT-OF-CARE DEVICE FOR SELF-PATIENT MANAGEMENT OF THE ORAL ANTICOAGULANT THERAPY

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CoaguPOC project word cloud

Explore the words cloud of the CoaguPOC project. It provides you a very rough idea of what is the project "CoaguPOC" about.

oat    prevent    10    18    pressure    clots    therapy    550    visits    death    mere    home    usually    western    events    healthcare       toxic    thrombotic    tests    life    adjustment    hospitals    frequent    dosing    50    first    67    coagulant       instance    world    coagupoc    led    unnecessary    chronic    families    monitor    coagulometers    dosage    narrow    strokes    risk    anticoagulants    saving    pocket    market    window    regular    hospital    hemorrhages    once    intensifying    nursing    quality    small    reductions    monitoring    million    leads    uk    lethal    approximately    potentially    confirm    12    savings    single    permitting    annually    constant    blood    seek    patients    made    anticoagulant    patient    correct    smart    substantial    clinics    service    levels    center    usual    self    device    drugs    therapeutic    oral    adverse    systemic    thrombosis    ready    care    people    give    lab    inhibit    point    population    2nd    anti    prescribed   

Project "CoaguPOC" data sheet

The following table provides information about the project.

Coordinator
RELOGABLE S.L. 

Organization address
address: C/ POLLENSA 2 -DESPACHO 4.1
city: LAS ROZAS DE MADRID
postcode: 28290
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://www.relogable.com/projects.html
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-05-01   to  2017-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    RELOGABLE S.L. ES (LAS ROZAS DE MADRID) coordinator 50˙000.00

Map

 Project objective

The goal we seek in CoaguPOC project is to develop a “ready to the market” smart point-of-care device for self-patient management of the Oral Anticoagulant Therapy (OAT). OAT is a long-term or even chronic therapy necessary to inhibit the formation of potentially lethal blood clots in patients with high risk of thrombosis; e.g. strokes, the 2nd single largest cause of death in the world. Approximately 2% of the population are prescribed long-term oral anticoagulants, meaning that more than 10-12 million people are treated in Western Europe.

OAT therapy needs regular tests to confirm correct dosage levels because the drugs have a narrow therapeutic window and small changes in systemic changes can give rise to adverse toxic effects. Tests are usually made once a month in a nursing service at the hospital or care center. The constant increase on the number of anti-coagulant patients (around 10% annually) is highly intensifying pressure and cost on the healthcare resources required to monitor, prevent and manage adverse events.

The use of point-of-care coagulometers at home for self-monitoring may avoid unnecessary visits to hospitals or clinics while permitting more frequent monitoring and timely adjustment of anticoagulant dosing to avoid adverse events. The OAT self-management leads to important reductions on adverse events, as thrombosis (reduction by 50%), major hemorrhages (12%), death (18%) and thrombotic events (67%) as compared to ‘usual care‘. It also has a substantial impact on the quality of life of patients and their families, and important cost savings on the healthcare system. For instance, in UK a mere increase of 5% improved in average therapeutic range, led to a reduction of 550 strokes per year and associated cost saving of around €12,000 per patient.

CoaguPOC aims bringing to the market the first low-cost and smart point of care device for OAT patients to self-monitor and self-manage their chronic condition. We aim to bring the lab to your pocket

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "COAGUPOC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "COAGUPOC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

ImmuneHunter (2017)

Bioinformatics platform for profiling of health: allowing early and accurate detection of multiple diseases simultaneously

Read More  

SensUS (2018)

SensUS: A non-invasive and quantitative ultrasound (QUS) device for an objective monitoring of the childbirth labour process.

Read More